High- and Low-Affinity Epidermal Growth Factor Receptor-Ligand Interactions Activate Distinct Signaling Pathways
Jordan A. Krall(Harvard University), Gavin MacBeath(Harvard University)
Cited by 103
Related Papers
Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121)
|npj Systems Biology and Applications|2017|76